US-India Cooperation Raises Hopes, Concerns

India PM Modi at US-India Business Council

In this week’s highly anticipated visit to the United States by Indian Prime Minister Narendra Modi, a number of joint statements have been issued, raising hope for greater cooperation between the two countries, and some concern about the same.

Health Advocates Demand U-Turn In EU Trade Policy To Align With Its Health Objectives

FLickr -  Greg McMullin -

Health Action International Europe, and Oxfam today issued a briefing paper entitled, “Trading Away Access to Medicines: How the European trade agenda continues to undermine access to medicines.” The paper argues that new concerns such as the ebola virus and the threat of unchecked antimicrobial resistance show the need for a new model for financing pharmaceutical research and development.

Panellists Discuss Value Of Patent Pooling For HIV/AIDS, Potential For Other Diseases

MPP's Greg Perry speaks, flanked by Duneston (left), Mirza (right), and other panellists

A side event to this week’s World Intellectual Property Organization annual General Assembly highlighted the work of the Geneva-based Medicines Patent Pool in fighting HIV/AIDS, and discussed whether it makes sense for the patent pool model to be extended to other diseases.

Gilead Monopoly Prevails Over Non-Discriminatory Access As Debated Hepatitis C Deal Sets Off

Cost of Medicines

Gilead on 15 September struck voluntary licence deals with seven India-based generic manufacturers to expand access to its hepatitis C innovative drugs in developing countries. With a limited territory covered, this, yet deserving, pact raises doubts about the coherence of Indian counterparts at a time when there are no relevant patents in India, several pre-grant oppositions have been filed and unrestrained competition by compulsory licences could have been pursued, writes Daniele Dionisio.

Numerous Side Events At WIPO General Assembly This Week

WIPO new building lobby atrium 1

A number of side events have been scheduled during the annual General Assemblies of the World Intellectual Property Organization this week. The range of events are organised by WIPO as well as governmental and non-governmental organisations working in areas such as public health, finance, copyright, geographical indications and innovation.

Experts Look At The Meaning Of Myriad Case, One Year Later

Cal Irvine law school myriad conf Sept 2014

IRVINE, CALIFORNIA – Experts gathered here last week addressed the question of – one year later – what does the United States Supreme Court’s decision on human gene patents mean for scientific research and patent policy?

Guest Post: Nine Mandatory Licences Allow Greater Access To Medicines In Ecuador

Health 1

What is a mandatory licence? Mandatory licenses are a legal remedy within the intellectual property flexibilities provided by the World Trade Organization allowing a government to grant permission to third parties to produce a patented product or use a patented process without the consent of the patentee, in order to address a priority status for the country.

Flexible IPR Approach For European Joint Innovation Projects

EU Flag

Applicants to the European “Innovation Communities” initiative have until 10 September to submit joint innovation proposals in the areas of healthy aging and raw materials. The aim is to create new organisations compliant with the European grant programme Horizon 2020, which will operate under flexible intellectual property rights’ policies in collaborative innovation projects.